Perez v. Wexford Health Sources, Inc.

CourtDistrict Court, N.D. Illinois
DecidedNovember 6, 2019
Docket1:17-cv-08386
StatusUnknown

This text of Perez v. Wexford Health Sources, Inc. (Perez v. Wexford Health Sources, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Perez v. Wexford Health Sources, Inc., (N.D. Ill. 2019).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

ISAAC PEREZ, ) ) Plaintiff, ) ) v. ) 1:17 C 8386 ) Hon. Marvin E. Aspen WEXFORD HEALTH SOURCES, INC, ) THE ESTATE OF SALEH OBAISI, M.D., ) and TIMOTHY J. FAHY, M.D., ) ) Defendant. )

MEMORANDUM OPINION AND ORDER MARVIN E. ASPEN, District Judge: Plaintiff Isaac Perez alleges that Dr. Timothy Fahy, Dr. Saleh Obaisi,1 and Wexford Health Sources, Inc. ("Wexford") were deliberately indifferent to his eye and back conditions during his incarceration at Stateville Correctional Center ("Stateville"). (Amend. Comp. (Dkt. No. 10) ¶¶ 1–4, 26, 30–32, 34–36.) Before us is Defendants' motion for summary judgment. (Mot. (Dkt. No. 52).) For the reasons set forth below, we grant Defendants' motion. BACKGROUND The facts outlined hereafter are taken from the parties’ Local Rule 56.1 statements and are undisputed unless otherwise noted. Perez is incarcerated and has been living at Stateville since 2013. (Defs.’ Statement of Facts (“Defs.’ Facts”) (Dkt. No. 53) ¶ 4.) Perez experienced recurring left eye and back

1 Dr. Obaisi is deceased and so his estate is listed as a party. His estate is represented by Independent Executor Ghaliah Obaisi. (Defs.' Statement of Undisputed Facts ("Defs.' Facts") (Dkt. No. 53) ¶ 7; Dkt. No. 28 (Substituting the Estate of Saleh Obaisi in place of Saleh Obaisi as a defendant in this case).) We refer to Dr. Obaisi’s estate, Dr. Fahy, and Wexford collectively as “Defendants.” problems while incarcerated that prompted him to seek medical treatment from the Illinois Department of Corrections ("IDOC"). IDOC provides care to inmates, in part, by contracting with Wexford. (Id. ¶ 5.) Wexford in turn hires physicians and other medical staff who provide direct care to Stateville’s inmates. (Id. ¶ 5.) Drs. Obaisi and Fahy were employed by Wexford

and provided medical care to Perez. (Id. ¶¶ 6–7, 22, 62.) I. PEREZ'S LEFT EYE Perez first started having eye problems while incarcerated in 2014. (Perez Decl. (Dkt. No. 62–1) ¶ 1; Perez Dep. (Dkt. No. 53–1) at 22.) Perez testified that blurry vision, watery eyes, and fluid discharge prompted him to request an appointment with an optometrist. (Perez Dep. at 22–23; Perez Decl. ¶¶ 1–2.) A. Perez’s Initial Eye Appointments Perez's eyes were initially examined in November 2014. (Pl.’s Add. Statement of Undisputed Facts ("Pl.’s Facts") (Dkt. No. 59) ¶ 3; Dkt. No. 59–1 at 2.) The examining optometrist observed that Perez complained of blurry vision in his left eye and may have had a previous episode of Central Serous Retinopathy ("CSR").2 (Dkt. No 59–1 at 2.) CSR occurs

when fluid accumulates in retinal tissue and can manifest as blurry or distorted vision, or grayness in the central area of a patient's vision. (Fahy Dep. at 6–7, 19; Defs.' Facts ¶ 25.) It is unknown what causes CSR, but it is often temporary. (Defs.’ Facts ¶ 25.) Perez’s eyes were examined again about nine months later. (Pl.’s Facts ¶ 5; Dkt. No. 59–2 at 2.) The examining physician noted that there was "no change in [Perez’s] Retina," and his left eye was "quiet." (Dkt. No. 59–2 at 2.)

2 CSR is also known as idiopathic central serous chorioretinopathy ("ICSC"), (Defs.’ Facts ¶ 25) and is referred to as such in some of the parties’ documents. We use CSR for consistency. B. Perez's Appointments with Dr. Fahy Dr. Fahy first saw Perez on December 2, 2016 for a general eye checkup. (Defs.' Facts ¶ 22; Fahy Dep. at 13.) Dr. Fahy did not review Perez's medical records before the checkup. (Fahy Dep. at 11.) Dr. Fahy observed that Perez had irritated eyelids and mucus

discharge from both eyes, and diagnosed him with "atopic conjunctivitis," for which he proscribed anti-inflammatory eyedrops. (Defs.' Facts ¶ 22; Perez’s Med. Recs. (Dkt. No. 57) at 64.) Dr. Fahy also ordered Perez glasses and told him to follow up in a week. (Defs.' Facts ¶ 22.) At Perez's follow-up appointment on December 12, 2016, Dr. Fahy diagnosed Perez with CSR in his left eye and referred him to an ophthalmologist. (Defs.' Facts ¶¶ 23–24, 51; Med. Recs. at 62.) Dr. Fahy testified that as an optometrist, his only treatment option when presented with CSR is to refer the patient to a specialist. (Fahy Dep. at 22; Defs.' Facts ¶ 52.) He also testified that he has previously encountered two patients with CSR and that he referred them both to an ophthalmologist. (Fahy Dep. at 9.)

Wexford utilizes a review process when patients are referred for offsite treatment or to a specialist. (Defs.’ Facts ¶ 18–19.) Referrals are reviewed by the "Wexford Collegial Review Board" ("Review Board") that consists of physicians and nurses who determine whether recommended treatments should be approved. (Id.) In December 2016, the Review Board approved Dr. Fahy's referral to an ophthalmologist and Perez was eventually scheduled for an appointment at the University of Illinois at Chicago's ("UIC") Ophthalmology clinic. (Id. ¶ 26.) C. Perez's Ophthalmology Appointment and Dr. Fahy Follow Up Perez was seen at UIC on May 11, 2017, approximately five months after Perez's appointment was approved. (Id. ¶ 28.) It is unclear why there was such a long delay, but it is

undisputed that Dr. Fahy does not have control over UIC’s scheduling processes. (Pl.'s Resp. to Defs.' Facts (Dkt. No. 59) ¶ 53.) The ophthalmologist that examined Perez did not diagnose him with CSR. (Defs.’ Facts ¶ 28; Med. Recs. at 62.) Rather, the UIC ophthalmologist diagnosed Perez with "myopia astigmatism" (nearsightedness), recommended that he wear his glasses full time, and instructed him to follow up in a year. (Defs.' Facts ¶¶ 28–29.)

Dr. Fahy saw Perez less than a week later and observed that the fluid in Perez's eyes were receding and his vision was improving, but Perez still had CSR. (Id. ¶ 31.) Dr. Fahy instructed Perez to follow up in three months or as needed if his vision worsened. (Id.) Dr. Fahy saw Perez again four months later. (Id. ¶ 32.) At the appointment, Perez complained that the vision in his left eye was reduced and that he had lost contrast sensitivity. (Id.) Dr. Fahy thereafter referred Perez to another specialist, however, instead of referring Perez to an ophthalmologist, he referred him to a retina specialist. (Id. ¶¶ 32–33.) A retina specialist is a tertiary care eye physician that is more highly specialized than an ophthalmologist. (Id. ¶ 51.) D. Perez's Retina Specialist Appointment and Dr. Fahy Follow Up On March 6, 2018, Perez was seen by a retina specialist, Dr. William F. Mieler.

(Id. ¶ 35.) Dr. Mieler diagnosed Perez with CSR and recommended he be treated with photodynamic therapy ("PDT"). (Id. ¶¶ 35–36.) But the Review Board did not approve Dr. Mieler’s recommendation for Perez to receive PDT. (Id. ¶ 39; Med. Recs. at 43.) Rather, it determined that Perez's diagnosis should be confirmed and that it needed "written confirmation" from UIC's Retina Clinic that PDT was an "FDA approved treatment for CSR." (Med. Recs. at 43; Defs.' Facts ¶ 39.) While the Review Board waited for confirmation, Dr. Fahy saw Perez again and noted that Perez’s vision was still blurry and he was experiencing light sensitivity for which Dr. Fahy ordered Perez tint for his glasses. (Defs.' Facts ¶ 40; Med. Recs. at 105.) Not long thereafter, a Wexford physician affirmed the Review Board's denial. (Defs.’ Facts ¶ 42.)

That Wexford physician concluded that PDT treatment should be denied because it is not FDA approved for the treatment of CSR and an article from UIC indicated that while PDT appears beneficial, further studies are needed. (Id.; Med. Recs. at 80.) Dr. Fahy saw Perez again on April 9, 2018. (Defs.’ Facts ¶ 43.) During the appointment, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Victor v. Nebraska
511 U.S. 1 (Supreme Court, 1994)
Mathis v. Fairman
120 F.3d 88 (Seventh Circuit, 1997)
Donald F. Greeno v. George Daley
414 F.3d 645 (Seventh Circuit, 2005)
Deidre Davis v. Yolanda Carter
452 F.3d 686 (Seventh Circuit, 2006)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Gayton v. McCoy
593 F.3d 610 (Seventh Circuit, 2010)
Duckworth v. Ahmad
532 F.3d 675 (Seventh Circuit, 2008)
People v. Lawler
568 N.E.2d 895 (Illinois Supreme Court, 1991)
Earnest D. Shields v. Illinois Department of Correct
746 F.3d 782 (Seventh Circuit, 2014)
Ronald Ruhl v. Marcus Hardy
743 F.3d 1083 (Seventh Circuit, 2014)
Kevin Dixon v. Cook County, Illinois
819 F.3d 343 (Seventh Circuit, 2016)
Tyrone Petties v. Imhotep Carter
836 F.3d 722 (Seventh Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Perez v. Wexford Health Sources, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/perez-v-wexford-health-sources-inc-ilnd-2019.